Please login to the form below

Not currently logged in
Email:
Password:

HTA

This page shows the latest HTA news and features for those working in and with pharma, biotech and healthcare.

NICE launches consultation on its methods of drug evaluation

NICE launches consultation on its methods of drug evaluation

diagnostics. The health technology assessment (HTA) agency launched a public consultation last week on a proposal for changes to the methods it uses to evaluate potential medical treatments. ... The HTA agency has already identified potential areas for

Latest news

More from news
Approximately 32 fully matching, plus 150 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 14 fully matching, plus 63 partially matching documents found.

Latest appointments

  • Open Access Consulting appoints new director Open Access Consulting appoints new director

    value dossiers, payer-focused objection handlers, stand-alone payer value propositions and local HTA submissions.

  • Claes Buxfeldt joins NDA Claes Buxfeldt joins NDA

    He becomes its new HTA director. AstraZeneca’s former global price and reimbursement director Claes Buxfeldt has joined the NDA advisory board. ... Buxfeldt’s new role at NDA will see him drive and develop the group’s service offerings in the HTA

  • Professor Carole Longson moves from NICE to the ABPI Professor Carole Longson moves from NICE to the ABPI

    She most recently spent the 18 years at the National Institute for Health and Care Excellence ( NICE), where she has led the HTA organisation’s technology appraisal programme.

  • VCLS appoints Carole Jones to senior market access role VCLS appoints Carole Jones to senior market access role

    her focus on expanding the company’s market access capabilities, spanning payer strategy, health economics and outcomes research (HEOR), health technology assessment (HTA) and communications support.

  • EFPIA's Richard Torbett to move to the ABPI EFPIA's Richard Torbett to move to the ABPI

    At the ABPI Torbett will focus on pricing, the Pharmaceutical Price Regulation Scheme (PPRS), health technology assessments (HTA) and value assessment, as well as market access in the UK.

More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 6 fully matching, plus 24 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics